2002 Call For Papers
AAPS Annual Meeting and Exposition
Deadline is May 7, 2002
|
Table of Contents
|
| |
|
Letter from the President
January 2, 2002
Dear Colleague:
It is our pleasure to officially announce the Call for Papers for the 2002 AAPS
Annual Meeting and Exposition. The meeting will take place November 10-14, 2002
at the Metro Toronto Convention Centre, Toronto, Canada. The online abstract
submission deadline is May 7, 2002.
Submission of your abstracts can be made online at
https://abstracts.aapspharmaceutica.com/aaps2002
Enclosed are detailed instructions for the abstract submission process. These
online instructions are for your reference when submitting your abstract via
the web. For those without web access, you can submit your abstract to AAPS via
diskette for a nominal fee. For more information on diskette submission go
here.
We look forward to your participation in the 2002 AAPS Annual Meeting and
Exposition. The preliminary program/registration booklet for this meeting will
be available in June. If you have any questions, please contact the AAPS
office, 2107 Wilson Blvd., Suite 700, Arlington, VA 22201; phone: 703-243-2800;
fax: 703-243-5582, or via email at
aaps@aaps.org.
Sincerely,
Diane J. Burgess, Ph.D.
AAPS President
Back To Top
Abstract Requirements
Abstract Submission
There are two ways to submit your abstract:
-
Online
Submissions can be made electronically by using the online submission system at:
https://abstracts.aapspharmaceutica.com/aaps2002
-
Diskette
For those without Internet access, you may send a 3.5-inch diskette with the
abstract submission pdf form.
Diskette submissions will be charged a $75.00 (US) processing fee.
Note: Faxed or emailed submissions will not be accepted.
Back to Top
Organization
All abstract submissions are required to be structured under these headings:
-
Purpose
-
Methods
-
Results
-
Conclusions
These headings are provided in the online submission process if you choose to
cut and paste your abstract. Place text for each heading in the appropriate
text box. If you are submitting via diskette, make sure that you structure your
abstract under these headings. Abstracts that are not organized in this manner
will not
be reviewed. If you have questions about the content or topic placement of your
abstract, call AAPS at 703-248-4792. It is crucial that you choose the correct
topic so that your abstract will be sent to the appropriate section for review
and presentation at the meeting.
Back to Top
Size
All abstracts must fit within the allotted size requirement to be considered
for review. The abstract must be
300 words
or less.
The submission system will not accept abstracts that are more than 300 words in
length.
Text should be in Times font only.The font size should be 12-point. Greek
letters and symbols may be placed in the abstract by clicking on the box in the
online submission process above the abstract text box. Graphics and tables are
equivalent to 25 words each.
Back to Top
Tables and Graphics
Authors may include tables and graphics in the abstract, as long as they fit
within the size requirement. When submitting your abstract electronically,
graphics and tables must be embedded into the abstract text and not linked. You
do not need to submit tables in a separate file.
Graphic files may be sent in any format (preferably .GIF or .JPEG). Remember
that your graphic will be printed in a 3.25-inch wide column. Make certain that
your graphic is clear and readable at this size. Graphics must have 300 dpi
resolution for clear reproduction.
Back to Top
Topics
Choose your topic carefully. The topic chosen for your abstract will be used
for assignment into poster sessions and screening sections. Double-check that
you have made the correct selection so it will be sent to the proper screeners
for review.
No changes can be made after the assignment.
Back to Top
Acceptance Criteria
Acceptance of the abstract for presentation will be based on the concise,
accurate presentation of new data. Criteria for rejection include lack of data,
commerciality, inconsistent or ambiguous data, reviews of literature, lack of
novelty or innovation, or failure to follow format guidelines.
Some sections have their own set of guidelines and criteria for acceptance.
Contact the screening chair for your
section if you are unsure of the guidelines. A specific abstract example has
been included by the APQ Section to help you in the submission process. This
example can be found on the first page of the submission system by clicking on
the style guide. Click
here
for a sample abstract.
It is imperative that data is presented in the results section so that AAPS
screeners can judge the scientific value of your abstract.
The submission of multiple abstracts covering the same or similar work is
discouraged. Authors are strongly encouraged to submit one strong abstract
instead of several abstracts presenting the work in Part I, Part II, Part III,
etc. Abstracts submitted in this fashion
will be rejected.
Back to Top
Notification of Receipt and Verification of Submission
When using the online submission form, you will receive immediate confirmation
via email with your control number included. Print this confirmation for future
reference. This notification only confirms receipt of your submission and is
not a notification of acceptance.
Back to Top
Screening/Presentation
The abstracts will be screened blindly, meaning no author affiliations will be
provided to those screening the abstracts.
Final assignment to poster or poster/podium (oral) presentations will be made
at the discretion of the screeners and according to the topic chosen by the
authors. If you are interested in presenting your work as a poster/podium
(oral), then you should pick the appropriate choice in the submission system.
This designation will alert the screeners to give your abstract consideration
for an oral presentation.
Note:
Not all sections have poster/podiums (oral presentations). Please verify that
your section has a poster/podium before selecting this option.
Back to Top
Notification of Acceptance
Abstract status notifications will be sent via email to all submitting authors
on July 8, 2002. If you do not receive this notification, please email AAPS at
abstracts@aaps.org
for an update on the status of your abstract.
If you did not use the online submission form, you will be mailed a
notification of acceptance or non-acceptance on July 5, 2001. Notifications
will be sent to the contact author only.
Back to Top
Abstract Revisions
Revisions to your abstract will not be allowed after submission. Please
proofread and spell check your abstract carefully before submitting it.
Abstracts will be printed
exactly
as they appear when submitted.
Back to Top
Abstract Appeals Process
If your abstract has been rejected and you would like to challenge the decision
please proceed as follows:
-
All appeals will first be communicated to AAPS at
appeal@aaps.org
within three days of notification.
-
The Screening Chair of the section to which you have submitted will review the
abstract again. You will then be contacted via email with the decision within a
week. All initial appeals will be adjudicated by
July 15, 2002.
-
If the Screening Chair upholds the original rejection, the author may then
appeal to the Section Chair via AAPS staff. The Section Chair will then contact
AAPS with his/her decision and AAPS will send an email to the author informing
him/her of the decision. The Section Chair has final say in all abstract
appeals for the 2002 AAPS Annual Meeting and Exposition. Any appeals to other
AAPS members will not be entertained.
-
All final abstract appeals will be adjudicated by
July 19, 2002.
No revisions or modifications to abstracts will be allowed. The work will be
reviewed as it was originally submitted. Authors may not supply additional data.
You must follow these steps in order to appeal your abstract rejection. Do not
go directly to the Section Chair, as he/she will refer you back to the Section
Screening Chair.
Back to Top
Abstract Withdrawal
To withdraw a submitted abstract, written notification (email, fax or letter)
must be sent to:
AAPS: Matthew McGee
2002 AAPS Annual Meeting and Exposition Abstracts
2107 Wilson Blvd., Suite 700
Arlington, VA 22201
Fax: 703-243-5582
McgeeM@aaps.org
This notification must include the abstract title, authors and affiliations,
the abstract confirmation number, and the name, affiliation, phone, fax and
email of the correspondent. AAPS will acknowledge all withdrawal notifications
by email, fax or letter. Due to publishing deadlines, withdrawal notifications
must be received by
June 28, 2002
to ensure withdrawal from publication.
Back to Top
Abstract Submission Deadlines:
-
Electronic Abstracts
The deadline for online submission of abstracts is 5:00 pm EST on May 7, 2002.
Use the following link to the online submission form:
https://abstracts.aapspharmaceutica.com/aaps2002
-
Paper Abstracts
Mailed submissions will be charged a $75 (US) fee that must be submitted with
the abstract. Payment must be via check or credit card (Visa, MasterCard,
Amex, Discover). The check should be made payable to AAPS-Abstracts.
Mailed diskette submissions must be received (not postmarked) by May 1, 2002 at
the following address:Mailed diskette submissions must be received (not
postmarked) by May 1, 2002 at the following address:
Mailed diskette submissions must be received (not postmarked) by May 1, 2002 at
the following address:
AAPS: Matthew McGee
2002 AAPS Annual Meeting and Exposition Abstracts
2107 Wilson Blvd., Suite 700
Arlington, VA 22201
Diskette and online submissions will both be notified on July 8, 2002.
Notifications will be sent to the contact author only.
Diskette submissions sent without payment will not be accepted.
Back to Top
Early Bird Submission Deadline
Win a free registration to the 2002 AAPS Annual Meeting and Exposition by
submitting your abstract by
April 30, 2002!
AAPS will select one winner from those abstracts submitted before the early
bird deadline for a complimentary registration to the 2002 AAPS Annual Meeting
and Exposition. Mailed diskette submissions must be received (not postmarked) by
April 30, 2002.
Do not contact AAPS to receive a deadline extension. DEADLINE EXTENSIONS WILL
NOT BE GRANTED UNDER ANY CIRCUMSTANCES!
Back To Top
Canadian Border Access
Access between the Canadian and U.S. border is very simple and easy. If you
have any questions or concerns regarding this matter, please contact AAPS at
877-998-1177. A member relations specialist will be able to answer any
questions that you may have about access between Canada and the United States.
Back To Top
Abstract Submission Instructions
Format Your Abstract
For online submission and diskette submission, format your abstract in a word
processing file, using Microsoft Word or WordPerfect.
PLEASE SUBMIT ONLY ONE ABSTRACT PER DISKETTE OR ONLINE ENTRY
-
All submissions
MUST
be in Time text only. The font size should be 12-point type. Verify that all
symbols are correct in your submission.
-
DO NOT INCLUDE THE TITLE IN THE ABSTRACT FILE.
The title will be captured on the online Web form.You should include the title
on the outside label of your diskette if you choose to submit in that format.
-
DO NOT INCLUDE AUTHOR AND INSTITUTION INFORMATION IN YOUR ACTUAL ABSTRACT
WORD FILE.
The online system will be used to gather this data.
-
When typing the abstract, observe the following:
-
Structure your abstract under the following headings: Purpose, Methods,
Results, and Conclusions.
-
You may include tables or graphics in the abstract. To ensure we receive the
tables in your file, embed the graphics, do not link them. All graphics must be
uploaded via the Website (preferably in .GIF or .JPG format).
-
If you need to acknowledge financial support received which enabled the
research to be conducted, start a new paragraph (with no blank line after
the abstract text) and type the acknowledgement. Place your acknowledgements
after the conclusion in the abstract text.
-
Review your abstract carefully when submitting. No changes in the content will
be allowed after submission.
Submit your abstract using the online submission system or complete the
diskette submission form.
/ Mail
the form and your abstract on diskette to the address provided under Paper
Abstract Submission Deadline.
Note: Failure to adhere to these format requirements will result in rejection
of the abstract.
Back To Top
Online Submission Method
The online submission form uses a special file upload feature. To take
advantage of this feature, you must use Netscape 3.0 or higher or Internet
Explorer 4.0 or higher. The site allows you to download these versions.
To access the online submission form, click
here.
We strongly recommend that you submit your abstract in Microsoft Word or
WordPerfect format (Windows or Macintosh).
NOTE: In rare cases, you may not be able to use all the features of the site if
your system administrator has configured a firewall to block "cookies." If this
is the case, contact your system administrator and request your system to allow
cookies. If this is not possible, use the
PDF form
and mail it with a diskette.
-
AAPS has included a new feature this year, which allows members to autofill all
of their contact information. AAPS Members should click on the member choice in
the system. Next, a prompt will appear asking for the membership identification
number. Once this is supplied, all of the necessary contact information is
automatically filled in. If you do not know your membership identification
number, contact AAPS at 877-998-1177 for assistance.
Not a Member Yet?
Visit
www.aapspharmaceutica.com/join
and fill out the easy application form today or call 877-998-AAPS for
more information about the many benefits being an AAPS Member offers you. Join
today!
-
Non-members cannot access the autofill feature and must provide all of the
required contact information.
Back To Top
Diskette/Mail Method
Diskette/Mail Method AAPS strongly encourages you to use the online submission
form. However, if you do not have access to the Internet or have technical
difficulties, you may submit your abstract by mail. Mailed submissions will be
charged a $75 (US) fee. This can be paid by check or credit card. Checks can be
made payable to AAPS-Abstracts. Abstracts sent without payment will not be
accepted.
-
Complete the
submission form.
-
Copy your abstract to a diskette.
-
Please do not include your title in the body of the abstract text. This should
be written on the label of the diskette along with the information below.
-
Label the diskette with your name, the title of the abstract, word processing
format, and the platform (Mac or Windows).
-
Mail one copy of the form and one copy of the diskette with your abstract on it
to:
AAPS: Matthew McGee
2002 AAPS Annual Meeting and Exposition Abstracts
2107 Wilson Blvd., Suite 700
Arlington, VA 22201-3046
-
All authors will receive a confirmation with a control number by mail, email or
fax. If you supply a valid email address, you will receive an email
confirmation.
Back To Top
Technical Help
If you are experiencing any difficulties in the submission process, contact
Matthew McGee at 703-248-4792.
Back To Top
Topic List for Annual Meeting Contributed Papers
Analysis and Pharmaceutical Quality
Analytical (Non-Biological and Biological Matrices)
01
Capillary Separation Techniques (i.e. Electrophoresis, Electrochromatography)
02
Chiral Analysis
03
Immunoassay
04
GC
Analytical (Non-Biological Matrices)
05
HPLC
06
Hyphenated Techniques (i.e. GC-MS, LC-MS, LC-NMR, LC-IR)
07
Spectroscopic Techniques
08
Validation
09
Other
Analytical (Biological Matrices)
10
HPLC
11
Hyphenated Techniques (i.e. GC-MS, LC-MS, LC-NMR, LC-IR)
12
Spectroscopic Techniques
13
Validation
14
Emerging Technologies
15
High Throughput Analysis
16
Microdialysis
17
Sample Preparation Strategies
18
Other
Biotechnology
(Biotechnology derived agents will include the following: proteins/peptides,
oligonucleotides, viral gene therapy, vaccines/antibodies as well as other
non-small bio-molecules)
19
Bioprocessing (Effects of Fermentation, Cell Culture, Recovery, etc.) and
Manufacturing
20
Analytical, Characterization, Formulation, Physical Pharmacy and Stability
21
Novel Controlled Release Devices
22
Nasal/Pulmonary/Oral/Parenteral/Transdermal/Others
23
Absorption/Transport/Bioavailability
24
Pharmacokinetics/Pharmacodynamics
25
Pharmacogenetics and Polymorphism (SNPs)
26
Pharmacogenomics (Gene Expression and Signaling), DNA Microarray / Gene Chips,
and Proteomics/Protein Chips
27
Ligand Binding Assays/Immunoassays
28
Analytical Validation/Statistics, and Biomarker Quantification
29
Cell-Based Bioassays, Apoptosis and Signal Transduction
30
Transporter/Receptor Regulation
31
Mechanism-Based Drug Design, Biopolymeric Vehicles and Linkers for Drug
Delivery and Release
32
Stem Cells, Cell Biology, Cancer Therapy and Other Therapeutics
33
Analysis, Delivery, Formulation and Stability
Clinical Sciences
34
Pharmacotherapy
35
Clinical Trial Design, Conduct, and Management
36
Special Patient Populations
37
Therapeutic Drug Monitoring
38
Clinical Drug Interactions/Adverse Reactions
39
Other Human Pharmacology/Toxicology
40
Biostatistics and Clinical Data Management
41
Clinical Pharmacokinetics, Pharmacodynamics, and Biomarkers
Drug Design and Discovery (formerly Medicinal and Natural Products Chemistry
Section)
42
Drug Design
43
Computational Chemistry
44
Peptidomimetics
45
Small Molecules
46
Other Drug Design
47
Drug Discovery
48
Molecular Diversity/Combinatorial Synthesis
49
Natural Products
50
Targets/Drug-Receptor Interactions
51
Structure-Activity Relationships
52
High Throughput Screening
Economic Marketing and Management Sciences
53
Pharmacoeconomics/Outcomes Assessment
54
Pharmaceutical Pricing and Decision Analysis
55
Healthcare Economics, Pharmacoepidemiology, and Public Policy
56
Physician/Patient Decision Making and Behavior
57
Pharmaceutical Product Management & Promotions
58
Marketing Research Techniques
59
Pharmaceutical Distribution and Outsourcing
60
E-Business Strategies
61
Corporate Culture
62
Mergers, Acquisitions and Strategic Alliances
63
Leadership & Team Building
64
Sales Force Management/Performance
Pharmaceutics and Drug Delivery
65
Passive Permeability
66
Biopharmaceutics, Oral Absorption
67
Transporters
68
Efflux Pumps
69
Dermal/Topical Absorption
70
In Vitro-In Vivo
Correlations
71
Drug Delivery (Epithelial)
72
Drug Delivery (Dosage Forms)
73
Physical Pharmacy I (Systems, Characteristics, Performance)
74
Physical Pharmacy II (Materials Science)
Pharmaceutical Technologies
75
Aerosols
76
Controlled Release Systems
77
Liquids and Semisolids
78
Parenterals
79
Solids
80
Transdermals
81
Process Scale-Up, Validation, and Technology Transfer
82
Dissolution (Including
In-Vitro-In-Vivo
Correlations)
83
Preformulation/Physical Pharmacy
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism
84
In-Vitro
Metabolism
85
In-Vivo
Metabolism
86
Other Metabolism
87
Bioavailability, Bioequivalence, and Food Effects
88
Transporters
89
Preclinical PK/PD
90
Clinical PK/PD
91
Drug Interactions
92
Population PK/PD Analysis and Simulations
93
Absorption/First Pass Metabolism
94
Tissue Distribution
95
Microdialysis
96
Other Pharmacokinetics and Pharmacodynamics
Regulatory Sciences
97
GCP/GLP/GMP Compliance/Inspections
98
Bioavailability/Bioequivalence-Regulatory Implications
99
Bioanalytical-Method Validation
100
Biotechnology-Method Validation
101
Regulatory/Regulatory Specifications/Regulations
102
International Conference on Harmonization
103
Process/Computer/Analytical Validation
104
Global Dossier/CTD/NDA/ANDA/BLA/IND
105
Purity/Impurities/Qualification
106
Stability/Shelf-Life of Marketed Products
Back To Top
2002 AAPS Annual Meeting Contributed Papers Screening Committee
Partha Mukherjee, Ph.D.
APQ Screening Chair
Pfizer Inc.
2800 Plymouth Rd.
Ann Arbor, MI 48105
Phone: 734-622-2313
Fax: 734-622-2716
Email:
partha.mukherjee@pfizer.com
Ah-Ng "Tony" Kong, Ph.D.
BIOTEC Screening Chair
Rutgers University
College of Pharmacy, Dept. of Pharmaceutics
160 Frelinghuysen Rd., Rm. 228
Piscataway, NJ 08854-8020
Phone: 732-445-7335
Fax: 732-445-3134
Email:
kongt@cop.rutgers.edu
Henry Pieniaszek, Ph.D.
CS Screening Chair
DuPont Pharmaceuticals Company
PO Box 30
Newark, DE 19714
Phone: 302-366-5577
Fax: 302-451-0054
Email:
henry.j.pieniaszek@dupontpharma.com
Ian Haworth, Ph.D.
DDD Screening Chair
University of Southern California
Dept. of Pharmaceutical Sciences
1985 Zonal Ave.
Los Angeles, CA 90089
Phone: 323-442-3310
Fax: 323-442-1390
Email:
ihaworth@hsc.usc.edu
Thani Jambulingam, Ph.D.
EMMS Screening Chair
St. Joseph's University
5600 City Line Ave.
244 Mandevl
Philadelphia, PA 19131
Phone: 610-660-3382
Fax: 610-660-3365
Email:
tjambuli@sju.edu
Charles Asbill, Ph.D.
PDD Screening Chair
Samford University
McWhorter School of Pharmacy
800 Lakeshore Drive
Birmingham, AL 35229
Phone: 205-726-2997
Fax: 205-726-2088
Email:
csasbill@samford.edu
Lane Brunner, Ph.D.
PPDM Screening Chair
University of Texas at Austin
College of Pharmacy
Austin, TX 78712-1074
Phone: 512-471-0942
Fax: 512-471-7474
Email:
lane.brunner@mail.utexas.edu
Brad Clark, Ph.D.
PT Screening Chair
Pharmacia Corporation
4901 Searle Pkwy.
Skokie, IL 60077
Phone: 847-982-8463
Fax: 847-982-4900
Email:
brad.a.clark@pharmacia.com
Gopi Vudathala, Ph.D.
RS Screening Chair
Sanofi-Synthelabo, Inc.
9 Great Valley Pkwy, Bldg. 31
Malvern, PA 19355
Phone: 610-889-6394
Fax: 610-889-6919
Email:
gopi.vudathala@sanofi-synthelabo.com
Kevin Sweeney, Ph.D.
EC Liaison
University of Connecticut
School of Pharmacy
263 Farmington Ave.
Farmington, CT 06030
Phone: 860-486-2216
Fax: 860-679-3274
Email:
kevin.sweeney@uconn.edu
Mark Rogge, Ph.D.
AMPC Chair
Immunex Corporation
51 University St.
Seattle, WA 98101-2936
Phone: 206-381-6329
Fax: 206-624-2430
Email:
roggem@immunex.com
Steven Nail, Ph.D.
AMPC Co-Chair
Purdue University
1336 Robert E. Heine Bldg.
West Lafayette, IN 47907-1336
Phone: 765-494-1401
Fax: 765-494-6545
Email:
slnail@pharmacy.purdue.edu
AAPS Staff Liaison
Matt McGee
Abstract Coordinator
AAPS
2107 Wilson Blvd.
Suite 700
Arlington, VA 22201
Phone: 703-248-4792
Fax: 703-243-5582
Email:
McGeeM@aaps.org
Note: Do not send abstracts to the screeners.
Abstracts must be submitted according to the Call for Papers.
Back To Top
2002 AAPS Annual Meeting and Exposition Preliminary Program Outline
Sunday, November 10
Morning
AAPS Short Courses
Transfer and Cross Validation of Analytical and Bioanalytical Methods
R&D-Marketing; Interface: When the Two Worlds Meet
Liposomes in Drug and Vaccine Delivery: View from the Top
Pharmacogenomics in Clinical Drug Development
Drugs: Emulsions, Microemulsions and Advances in Wet Granulation Technology for
Solid Oral Dosage Forms
Drug Law Basics for Pharmaceutical Scientists
Understanding Amorphous Pharmaceutical Systems
12:00 pm - 1:15 pm
Short Course Luncheon
Afternoon
Short Courses Continue
AAPS Opening Ceremonies
AAPS Welcome Reception
Back To Top
Monday, November 11
Morning
AAPS Plenary Session
12:00 pm - 5:30 pm
AAPS Luncheon for Graduate Students and Postdoctoral Fellows
Contemporary Tools for Studying Drug Metabolism Poster Podium
Afternoon
AAPS Exposition
Symposia
Managing the Multi-National Megatrial
Block Copolymers as Drug Carriers: A Solution for Poorly Water Soluble Drugs
Challenges and Solutions for Successful Development and Validation of
Cell-Based Bioassays in Drug Development
Analytical Chemistry Challenges in Early Drug Development
Transporter-Based Clinically Significant Drug Interactions
Sponsor-FDA Drug Development Meetings: Case Studies, New Trends, Challenges and
Opportunities
Roundtables
Evaluating Drug-To-OTC Switches and Strategies for Success
New Analytical Technology for In Situ Analysis of Dosage Forms: Laser Induced
Breakdown Spectroscopy
Use of Whole Blood in Pharmacokinetic Evaluations
Contributed Papers Poster Session
Evening
Section Membership Meetings
CS, EMMS, RS and APQ
Back To Top
Tuesday, November 12
7:00 am - 8:15 am
Sunrise Schools
Effective Communication for Modelers and Simulation Scientists
Antisense Oligonucleotides-Formulation Options for a New Class of Drugs
Methodologies in the Solid State Characterization of Drug Substances
Fundamentals of Membrane Transporters: An Update on the In Vivo Role,
Polymorphism and Coordinate Regulation of P-Glycoprotein
Morning
AAPS Exposition
Symposia
PPDM/CS Graduate Symposium
PDD/PT Graduate Symposium
Drug Regulation vs. Antimicrobial Resistance
Pharmaceutical Applications of Near-Infrared Spectroscopy: From Discovery to
Commercialization
Alternative Methods of Terminal Sterilization for Proteins, Peptides and
Biopolymers
Surface Modified Particulate Systems for Targeted Drug Delivery
Measuring the Economic Returns from E Business Initiatives
New Strategies for the Development of Improved Analgesics
Integration of Biotechnology into Mainstream Biopharmaceutics Roundtable
Contributed Papers Poster Session
12:00 pm - 1:15 pm
Post-Approval Changes in Drug Substance Manufacturing and Selection of Starting
Materials Roundtable
Research Achievement Award Luncheon
Afternoon
AAPS Exposition
Symposia
APQ Graduate Symposium
BIOTEC Graduate Symposium
New Drug Developments in the Cardiovascular Field
Is it Time for a Data and Safety Monitoring Board Guidance?
Recent Advances in Polymorph Screening
Pharmaceutical Pricing in Global Markets
Bayesian Methods in Population PK/PD Modeling and Simulation
Challenges in Analysis of Large Molecules: Instruments, Procedures and Their
Validation
P450 Pro-Drug Activation-Based Cancer Gene Therapy Roundtable
Herbal Product Standardization Poster Podium
Contributed Papers Poster Session
Evening
Section Membership Meetings
PT, PPDM, PDD, DDD and BIOTEC
Back To Top
Wednesday, November 13
7:00 am - 8:15 am
Sunrise Schools
Metabonomics
How to Write Master Batch Records
Methodologies in Solid State Characterization of Drug Substances
Clinical Trial Simulation: A Primer
Morning
AAPS Exposition
Symposia
Phase Transformations During Pharmaceutical Processing
Pro-Drugs: Understanding the Challenges and Reaping the Rewards
Achievement, Validation and Monitoring of Selectivity in Liquid
Chromatography-Mass Spectroscopy
Pharmaceutical Applications of PEG Conjugation
Technological Approaches to Transdermal Drug Delivery
Pharmacogenomics of Drug Metabolizing Enzymes
Roundtables
Ensuring the Quality and Quantity of Future Pharmaceutical Scientists Through
Graduate Education
New Theories for Transport Across Lipid Bi-Layers
Modeling Baseline Data
DDD Poster Podium
Contributed Papers Poster Session
12:00 pm - 1:15 pm
Hot Topic Discussions - Aseptic Processing
Research Achievement Award Luncheon
Afternoon
AAPS Exposition
Symposia
Strategies of Development of Toxicology Formulations and Dealing with
Impurities in Drug Substance and Degradants in Clinical Formulation
Laboratory Automation in Early Pharmaceutical Development
Container Closure Seal Integrity
Outsourcing Strategies for Preclinical Biotechnology Development Programs
Pharmacogenomics of Membrane Transporters: Implications to Pharmacokinetics and
Pharmacodynamics
Recipe for Drug Interactions: Herbs, Spices, Vitamins, Minerals and OTC Products
Roundtables
Regulatory Issues Between the FDA and Europe-Finding the Common Ground
Generic Biologics-Does it Make Sense?
Update on Targeted Product Info
Population PK/PD Modeling at the Cutting Edge Poster Podium
Contributed Papers Poster Session
Graduate Symposium-Education Beyond Graduate Studies to Become Successful
Industrial Scientists
Back To Top
Thursday, November 14
Morning
Symposia
Excipient Functionality and Harmonization Update
Transbuccal Drug Delivery
Emerging Analytical Techniques: The Use of Positron Emission Tomography in Drug
Development
Novel Methods to Explore the Role and Mechanism of Action of Multidrug
Resistance Transporters in Drug Disposition
Pharmacogenomics/Proteomics in Drug Design and Discovery
Formulation Screening Strategies and Protein Stability Estimation
Roundtables
Development Issues with Fast to Humans Approach: Advantages and Pitfalls
Drug-Disease Interaction: A Source of Inter-Subject Variability in Drug
Development and Pharmacotherapy
Presentation and Discussion of the New Canadian Guidance for Clinical Trials
Contributed Papers Poster Session
Back To Top
Graduate Award Programs
The following graduate programs will take place during the 2002 AAPS Annual
Meeting and Exposition:
-
AAPS Graduate Symposium in Analysis and Pharmaceutical Quality
-
AAPS Graduate Symposium in Biotechnology
-
AAPS Graduate Symposium in Drug Delivery and Pharmaceutical Technology
-
AAPS Graduate Symposium in Pharmacokinetics, Pharmacodynamics and Clinical
Sciences
-
AAPS Outstanding Graduate Research Awards in Pharmaceutical Technologies
If you are submitting your abstract for any of the above graduate programs, you
must submit your abstract in accordance with the Call for Papers and also
submit the completed nomination package (nomination requirements for the
graduate programs are enclosed with this mailing to all graduate students).
Applicants to the Graduate Awards Programs must submit their abstracts using
the online submission as outlined in this mailing. Be sure to submit your
abstract in advance of the Graduate Awards Program deadline of
April 8, 2002
for all of the graduate programs except the graduate program in Pharmaceutical
Technologies, which has a deadline of
May 13, 2002.
You must submit your abstract online
before
these deadlines, as your abstract confirmation number is required on the
official nomination form to be considered for the award. Also, prepare your
abstract in the four inches wide by seven inches tall format and provide a hard
copy to be included with the Graduate Awards Program Nomination Package. If
you have any questions about the awards program, contact Carole Aikman at
703-248-4781 or email
AikmanC@aaps.org.
Deadline: April 8, 2002 for Graduate Awards Program
May 13, 2002 for Outstanding Graduate Research Awards Program in Pharmaceutical
Technologies
Note: Abstracts must be submitted online before these dates.
Back To Top
| 
